NeurOp, Inc. is a biotechnology company developing new medicines for central nervous system disorders including depression, neuropathic pain, ischemia (stroke), schizophrenia, and Alzheimer’s and Parkinson’s diseases.

Latest News

Lee Latimer Elected to ACS 2016 Board of Directors


Our Science

Our compounds are designed to target various subunits of N-methyl-D-aspartate (NMDA) receptors.

About Us

Our expertise in a critical signaling pathway in the central nervous system is leading to promising drug compounds.